logo KAN
You are here >   Home
  |  Login

Bio Availability / Bio Equivalence (BA/ BE)

Bioavailability/Bioequivalence Services at Pharma Metric Lab
are conducted according to GCP and ISO 17025/GLP compliance.
Our facilities had been audited by BPOM (Indonesian FDA),
National Accreditation Body (KAN) and
customers from Indonesia and Malaysia.
Read more

Clinical Studies

Clinical Studies

Our services are monitoring and project management.
We provide regular ICH GCP training for our CRAs
to ensure the highest working standards.
They are very cooperative, having good
relationships with the sites
Read more

Independent Ethics

Independent Ethics Committee Submission

Pharma Metric Labs helps clients in
preparing the necessary documents for submission
to the independent ethics committee.
Read more


Regulatory Submission

Our team are from leading pharmaceutical companies
who brings global experience to every assignment.
We understand the entire drug development
process and the regulation which shape the industry,
including GMP, GLP and GCP.
Read more

Subject Recruitment

Subject Recruitment, Screening, & Management

We maintain an active database of volunteers
for BA/BE study. Prior to each study,
we screen our volunteers at an
ISO-certified clinical testing laboratory
to ensure that the study volunteers
meet the inclusion criteria
Read more

Other Services

Other Services

   Data Management and Data Analysis
   Study Report Writing
   Comparative Dissolution Testing
   Analytical Laboratory Services


PT. Pharma Metric Labs (PML) has been announced and certified as one of the accredited Bioavailability/Bioequivalence (BA/BE) Center by National Pharmaceutical Control Bureau (NPCB), Ministry of Health, Malaysia since 2 October 2013. After passing a thorough inspection of Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) compliances, PML is now certified and listed in the NPCB Malaysia Compliance Programme for BA/BE Center.

This certification allows PML to continue providing BA/BE service to pharmaceutical industries in Malaysia as well as other pharmaceutical industries intending to market their products in Malaysia. This achievement also serves as confirmation of PML team competence and commitment to quality research.

Congratulation for this important new milestone!